President Trump has already caused consternation in pharma with his attacks on industry prices and his worrying promises to slash regulations at the FDA.
Amid concerns that millions of children are unprotected against potentially lethal diseases, NICE has published a new draft quality standard setting out how to drive up the
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho